TOVX · Theriva Biologics, Inc.
AI read · Neutral
The AI's read
That could help Theriva meet NYSE American's per-share price rules and support its listing. But the share count and authorized share count both shrink proportionally, and no cash is raised. The filing reports no change to its drug programs, so the listing benefit does not show a broader business change.